www.medical-devices.tech
15
'24
Written on Modified on
GE HealthCare News
GE HEALTHCARE’S MIM SOFTWARE INTRODUCES MIM SYMPHONY HDR PROSTATE FOR MR IMAGE GUIDANCE DURING PROCEDURES
Guidance from preoperative magnetic resonance imaging (MRI) helps clinicians deliver more precise high dose-rate (HDR) prostate brachytherapy treatments.
www.gehealthcare.com
GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence (AI) solutions, introduces MIM Symphony HDR Prostate to support high dose-rate (HDR) brachytherapy. This innovative solution aims to increase clinician confidence and help improve patient outcomes by providing direct tumour visualization from magnetic resonance imaging (MRI) scans during live ultrasound procedures for HDR prostate treatments.
MIM Symphony HDR Prostate stands out in the market by correcting MRI orientation and offering MRI guidance during HDR prostate procedures.
HDR brachytherapy is a prostate cancer treatment that involves implanting radioactive sources into the prostate gland via needles. Typically, clinicians use computed tomography (CT) or ultrasound imaging for planning these procedures. Incorporating MRI into brachytherapy treatment planning can reduce toxicity to critical structures. However, the challenge of accurately aligning MRI contours with live ultrasound images has hindered the use of MRI in HDR treatments.
GE HealthCare’s MIM Software developed MIM Symphony HDR Prostate to align contours on preoperatively acquired MRI with live ultrasound, providing clear visibility of the prostate, lesions, and critical structures during HDR prostate procedures. Aligning the MRI contours with the ultrasound assists clinicians in precise needle placement by:
- Defining the lesion and tracking changes to guide needle placement, even as the prostate moves during the procedure;
- Correcting differences between MRI supine and ultrasound lithotomy orientations with ReSlicer, a tool in MIM Symphony HDR Prostate; and
- Automatically digitizing needles on CT or ultrasound planning images as well as performing needle review and free length checks.
This new solution is the latest addition to GE HealthCare’s MIM Software portfolio of vendor-neutral solutions for radiation oncology. Following the recent acquisition of MIM Software’s portfolio – including MIM Maestro, Contour ProtégéAI+, and MIM Symphony LDR – GE HealthCare continues to offer a broad portfolio of solutions across precision imaging and radiopharmaceuticals as well as seamless interoperability of radiation oncology departmental systems to drive efficiency and optimize care across care pathways.
